Furthermore, two independent studies consistently reported abnormally elevated levels of lopinavir and ritonavir in COVID-19 patients, suggesting that this could be due to the negative regulation of CYP3A [73,74,75]. The gene discussed is CYP3A4; the disease is COVID-19.